Mayo Clinic CAR-T Cell Therapy Program

The CAR-T Cell Therapy Program at Mayo Clinic Comprehensive Cancer Center offers hope through a new cancer immunotherapy approved to treat certain blood cancers and currently undergoing clinical studies to treat other types of cancer. At Mayo Clinic in Rochester, Minnesota, you will have access to CAR-T cell therapy as a treatment option for cancers that have relapsed or have not responded to initial treatment, including B-cell acute lymphoblastic leukemia, B-cell non-Hodgkin's lymphoma, mantle cell lymphoma, follicular lymphoma and myeloma. The Cancer Center is home to one of very few such programs at select medical centers in the nation with experts trained and certified to manage this treatment and care after infusion. Mayo Clinic is top-ranked in more specialties than any other hospital, according to U.S. News & World Report, and the Cancer Center continually ranks among the top hospitals in the U.S. for Cancer. Mayo Clinic Comprehensive Cancer Center is a National Cancer Institute (NCI)-designated comprehensive cancer center.